Free Trial

CONMED Q1 2024 Earnings Report

CONMED logo
$71.04 +3.35 (+4.95%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CONMED EPS Results

Actual EPS
$0.79
Consensus EPS
$0.74
Beat/Miss
Beat by +$0.05
One Year Ago EPS
N/A

CONMED Revenue Results

Actual Revenue
$312.27 million
Expected Revenue
$307.06 million
Beat/Miss
Beat by +$5.21 million
YoY Revenue Growth
N/A

CONMED Announcement Details

Quarter
Q1 2024
Time
N/A

CNMD Upcoming Earnings

CONMED will be holding an earnings conference call on Wednesday, February 5 at 4:30 PM Eastern. Interested parties can register for or listen to the call.

Conference Call Resources

CONMED Earnings Headlines

CONMED (NYSE:CNMD) & electroCore (NASDAQ:ECOR) Head-To-Head Survey
This red-hot crypto opportunity could slam shut soon
The situation is clear: Crypto is a HUGE hit with investors. Bitcoin became so outrageously popular that early adopters had a shot at absolutely outrageous 14,510% gains or more over the last decade. And it’s far from the only time traders had a shot at obscene gains on crypto. With Ethereum, lucky traders who put $1,000 in 5 years ago and held through the ups and downs would have seen it turn into a staggering $709,740. And now there is a NEW blockchain seeing rapid adoption…
See More CONMED Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CONMED? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CONMED and other key companies, straight to your email.

About CONMED

CONMED (NYSE:CNMD), a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

View CONMED Profile

More Earnings Resources from MarketBeat